Citation Tools

Download PDFPDF

THU0043 Autoantibody profiling in prostvac and ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events
Free

Download to a citation manager

Cite this article as:
Budde P, Marte J, Zucht H, et al
THU0043 Autoantibody profiling in prostvac and ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events